UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 263

Sortiert nach

Lumacaftor-ivacaftor in the treatment of cystic fibrosis: design, development and place in therapy

Drug design, development and therapy, 2019-07, Vol.13, p.2405-2412

Connett, G J

2019

Volltextzugriff (PDF)

The tracheal system of the Common Wasp (Vespula vulgaris) – A micro-CT study

Journal of insect physiology, 2023-09, Vol.149, p.104547-104547, Article 104547

2023

Volltextzugriff (PDF)

Use of 16S rRNA Gene Profiling by Terminal Restriction Fragment Length Polymorphism Analysis To Compare Bacterial Communities in Sputum and Mouthwash Samples from Patients with Cystic Fibrosis

Journal of Clinical Microbiology, 2006-07, Vol.44 (7), p.2601-2604

2006

Volltextzugriff (PDF)

Review article: enzyme supplementation in cystic fibrosis, chronic pancreatitis, pancreatic and periampullary cancer

Alimentary pharmacology & therapeutics, 2010-11, Vol.32 (s1), p.1-25

2010

Volltextzugriff (PDF)

Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis

Journal of cystic fibrosis, 2013-01, Vol.12 (1), p.22-28

2013

Volltextzugriff (PDF)

166 Improvements in inhalational treatment amongst children using the Philips I-neb insight online software

Journal of cystic fibrosis, 2015-06, Vol.14, p.S100-S100

2015

Volltextzugriff (PDF)

89 Novel targeted nitric oxide donor pro-drugs disrupt biofilms formed by clinical Pseudomonas aeruginosa isolates from cystic fibrosis patients

Journal of cystic fibrosis, 2017-06, Vol.16, p.S87-S87

2017

Volltextzugriff (PDF)

254 Feasibility of implementing cardiopulmonary exercise testing in a regional paediatric cystic fibrosis centre in the UK

Journal of cystic fibrosis, 2017-06, Vol.16, p.S127-S127

2017

Volltextzugriff (PDF)

P120 Adherence to elexacaftor/texacaftor/ivacaftor during the first 2 years of treatment in an adolescent population

Journal of cystic fibrosis, 2023-06, Vol.22, p.S100-S101

2023

Volltextzugriff (PDF)

P196 Use of nose clips for routine spirometry helps maximise forced expiratory outcome measures in cystic fibrosis clinics

Journal of cystic fibrosis, 2023-06, Vol.22, p.S125-S125

2023

Volltextzugriff (PDF)

WS03.05 Percentage days covered: what does it tell us about adherence to Kaftrio and Kalydeco®?

Journal of cystic fibrosis, 2022-06, Vol.21, p.S6-S7

2022

Volltextzugriff (PDF)

EPS3.01 A comparison of routine cough swabs vs a novel sputum sampling technique in a paediatric population

Journal of cystic fibrosis, 2024-06, Vol.23, p.S40-S41

2024

Volltextzugriff (PDF)

P460 Assessing the exercise capacity of adolescents with cystic fibrosis in the post elexacaftor/tezacaftor/ivacaftor era, via cardiopulmonary exercise test

Journal of cystic fibrosis, 2024-06, Vol.23, p.S208-S208

2024

Volltextzugriff (PDF)

WS20.6 Comparison of microbial composition in the lower airway of young children with and without cystic fibrosis using 16S rRNA gene pyrosequencing

Journal of cystic fibrosis, 2012-06, Vol.11, p.S46-S46

2012

Volltextzugriff (PDF)

G385 RATNO – Reducing Antibiotic Tolerance using Nitric Oxide in Cystic Fibrosis: report of a proof of concept clinical trial

Archives of disease in childhood, 2014-04, Vol.99 (Suppl 1), p.A159-A159

2014

Volltextzugriff (PDF)

Resolution of peanut allergy following bone marrow transplantation for primary immunodeficiency

Allergy (Copenhagen), 2005-04, Vol.60 (4), p.536-537

2005

Volltextzugriff (PDF)

74 An evaluation of treatment burden following initiation of TOBI® Podhaler® in patients with CF

Journal of cystic fibrosis, 2014-06, Vol.13, p.S65-S65

2014

Volltextzugriff (PDF)

A randomised controlled trial to assess the relative benefits of large volume spacers and nebulisers to treat acute asthma in hospital

Archives of disease in childhood, 1999-05, Vol.80 (5), p.421-423

1999

Volltextzugriff (PDF)

Case study 1: Cystic fibrosis and the pancreas - pancreatic enzyme supplementation for improved outcomes: Enzyme Supplementation in Cystic Fibrosis, Chronic Pancreatitis, Pancreatic and Periampullary Cancer

Alimentary pharmacology & therapeutics, 2010, Vol.32, p.6-11

CONNETT, G

2010

Volltextzugriff (PDF)

EPS5.08 Elexacaftor/tezacaftor/ ivacaftor reduces need for pancreatic enzymes, enteral feeding and omeprazole use without causing excessive weight gain: a 2-year observational study

Journal of cystic fibrosis, 2023-06, Vol.22, p.S51-S51

2023

Volltextzugriff (PDF)

P158 Elexacaftor, tezacaftor, ivacaftor (ETI) improves lung function but not rate of decline in a two year observational study of adolescents

Journal of cystic fibrosis, 2023-06, Vol.22, p.S113-S113

2023

Volltextzugriff (PDF)

112 Can vancomycin injection be nebulised successfully?

Journal of cystic fibrosis, 2011, Vol.10, p.S29-S29

2011

Volltextzugriff (PDF)

364 Unexpected side-effects of a clinical trial

Journal of cystic fibrosis, 2011, Vol.10, p.S93-S93

2011

Volltextzugriff (PDF)

An assessment of cystic fibrosis children's activity levels and their views on preferred forms of exercise during inpatient stays

Journal of cystic fibrosis, 2010, Vol.9, p.S70-S70

2010

Volltextzugriff (PDF)

P454 Body composition and peripheral muscle function in people with cystic fibrosis established on elexacaftor/tezacaftor/ivacaftor

Journal of cystic fibrosis, 2024-06, Vol.23, p.S206-S206

2024

Volltextzugriff (PDF)

1 – 25 von 263

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(243)
Mit Volltextzugriff
(233)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(263)
Japanisch
(23)

Erscheinungsjahr

n.n

Thema

Humans
(150)
Science & Technology
(136)
Life Sciences & Biomedicine
(133)
Male
(100)
Female
(98)
Biological And Medical Sciences
(76)
Medical Sciences
(75)
Middle Aged
(71)
Adult
(46)
Respiratory System
(39)
Aged
(37)
Child
(31)
General & Internal Medicine
(29)
Treatment Outcome
(24)
Chronic Obstructive Pulmonary Disease
(22)
Pediatrics
(22)
Pneumology
(22)
Child, Preschool
(21)
Follow-Up Studies
(21)
Adolescent
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Lumacaftor-ivacaftor in the treatment of cystic fibrosis: design, development and place in therapy

The tracheal system of the Common Wasp (Vespula vulgaris) – A micro-CT study

Use of 16S rRNA Gene Profiling by Terminal Restriction Fragment Length Polymorphism Analysis To Compare Bacterial Communities in Sputum and Mouthwash Samples from Patients with Cystic Fibrosis

Review article: enzyme supplementation in cystic fibrosis, chronic pancreatitis, pancreatic and periampullary cancer

Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis

166 Improvements in inhalational treatment amongst children using the Philips I-neb insight online software

89 Novel targeted nitric oxide donor pro-drugs disrupt biofilms formed by clinical Pseudomonas aeruginosa isolates from cystic fibrosis patients

254 Feasibility of implementing cardiopulmonary exercise testing in a regional paediatric cystic fibrosis centre in the UK

P120 Adherence to elexacaftor/texacaftor/ivacaftor during the first 2 years of treatment in an adolescent population

P196 Use of nose clips for routine spirometry helps maximise forced expiratory outcome measures in cystic fibrosis clinics

WS03.05 Percentage days covered: what does it tell us about adherence to Kaftrio and Kalydeco®?

EPS3.01 A comparison of routine cough swabs vs a novel sputum sampling technique in a paediatric population

P460 Assessing the exercise capacity of adolescents with cystic fibrosis in the post elexacaftor/tezacaftor/ivacaftor era, via cardiopulmonary exercise test

WS20.6 Comparison of microbial composition in the lower airway of young children with and without cystic fibrosis using 16S rRNA gene pyrosequencing

G385 RATNO – Reducing Antibiotic Tolerance using Nitric Oxide in Cystic Fibrosis: report of a proof of concept clinical trial

Resolution of peanut allergy following bone marrow transplantation for primary immunodeficiency

74 An evaluation of treatment burden following initiation of TOBI® Podhaler® in patients with CF

A randomised controlled trial to assess the relative benefits of large volume spacers and nebulisers to treat acute asthma in hospital

Case study 1: Cystic fibrosis and the pancreas - pancreatic enzyme supplementation for improved outcomes: Enzyme Supplementation in Cystic Fibrosis, Chronic Pancreatitis, Pancreatic and Periampullary Cancer

EPS5.08 Elexacaftor/tezacaftor/ ivacaftor reduces need for pancreatic enzymes, enteral feeding and omeprazole use without causing excessive weight gain: a 2-year observational study

P158 Elexacaftor, tezacaftor, ivacaftor (ETI) improves lung function but not rate of decline in a two year observational study of adolescents

112 Can vancomycin injection be nebulised successfully?

364 Unexpected side-effects of a clinical trial

An assessment of cystic fibrosis children's activity levels and their views on preferred forms of exercise during inpatient stays

P454 Body composition and peripheral muscle function in people with cystic fibrosis established on elexacaftor/tezacaftor/ivacaftor

Suchergebnisse filtern